Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy

JC Naviaux, MA Schuchbauer, K Li, L Wang… - Translational …, 2014 - nature.com
Autism spectrum disorders (ASDs) now affect 1–2% of the children born in the United States.
Hundreds of genetic, metabolic and environmental factors are known to increase the risk of …

Antipurinergic therapy corrects the autism-like features in the poly (IC) mouse model

RK Naviaux, Z Zolkipli, L Wang, T Nakayama… - PloS one, 2013 - journals.plos.org
Background Autism spectrum disorders (ASDs) are caused by both genetic and
environmental factors. Mitochondria act to connect genes and environment by regulating …

Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism

MM Hirsch, I Deckmann, J Santos-Terra, GZ Staevie… - …, 2020 - Elsevier
Autism spectrum disorder (ASD) is characterized by deficits in communication and social
interaction, restricted interests, and stereotyped behavior. Environmental factors, such as …

Pathophysiological studies of monoaminergic neurotransmission systems in valproic acid-induced model of autism spectrum disorder

HY Kuo, FC Liu - Biomedicines, 2022 - mdpi.com
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with complex etiology.
The core syndromes of ASD are deficits in social communication and self-restricted interests …

Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model

JC Naviaux, L Wang, K Li, AT Bright, WA Alaynick… - Molecular autism, 2015 - Springer
Background This study was designed to test a new approach to drug treatment of autism
spectrum disorders (ASDs) in the Fragile X (Fmr1) knockout mouse model. Methods We …

Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder

Z Zolkipli-Cunningham, JC Naviaux, T Nakayama… - PloS one, 2021 - journals.plos.org
Since 2012, studies in mice, rats, and humans have suggested that abnormalities in
purinergic signaling may be a final common pathway for many genetic and environmental …

[HTML][HTML] Molecular pathology and pharmacological treatment of autism spectrum disorder-like phenotypes using rodent models

HY Kuo, FC Liu - Frontiers in cellular neuroscience, 2018 - frontiersin.org
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder with a
high prevalence rate. The core symptoms of ASD patients are impaired social …

Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally

CE Barrett, TM Hennessey, KM Gordon, SJ Ryan… - Molecular autism, 2017 - Springer
Background The amygdala controls socioemotional behavior and has consistently been
implicated in the etiology of autism spectrum disorder (ASD). Precocious amygdala …

Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid

M Servadio, F Melancia, A Manduca, A Di Masi… - Translational …, 2016 - nature.com
Autism spectrum disorders (ASD) are characterized by altered sociability, compromised
communication and stereotyped/repetitive behaviors, for which no specific treatments are …

Low‐dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial

RK Naviaux, B Curtis, K Li, JC Naviaux… - Annals of Clinical …, 2017 - Wiley Online Library
Objective No drug is yet approved to treat the core symptoms of autism spectrum disorder
(ASD). Low‐dose suramin was effective in the maternal immune activation and Fragile X …